Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews
X.M. Hart, Luzie Eichentopf, Xenija Lense, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 22

Showing 22 citing articles:

Pharmacogenomics in treatment of depression and psychosis: an update
Marin M. Jukić, F. Milosavljević, Espen Molden, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 12, pp. 1055-1069
Open Access | Times Cited: 43
Overview of therapeutic drug monitoring and clinical practice
Zijun Fang, He Zhang, Jiuchuan Guo, et al.
Talanta (2023) Vol. 266, pp. 124996-124996
Closed Access | Times Cited: 33
Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis
X.M. Hart, Christoph Hiemke, Luzie Eichentopf, et al.
Psychopharmacology (2022) Vol. 239, Iss. 11, pp. 3377-3391
Open Access | Times Cited: 26
How to Determine a Therapeutic Reference Range for a Psychotropic Drug Systematically? Recommendations of the TDM Task Force of the AGNP
X.M. Hart, Friederike Amann, Pierre Baumann, et al.
Therapeutic Drug Monitoring (2025)
Closed Access
Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors
Cleo S. M. Funk, X.M. Hart, Gerhard Gründer, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 15
Venlafaxine’s therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis
Xenija Lense, Christoph Hiemke, Cleo S. M. Funk, et al.
Psychopharmacology (2023) Vol. 241, Iss. 2, pp. 275-289
Open Access | Times Cited: 7
Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy
Luzie Eichentopf, Christoph Hiemke, Andreas Conca, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 11
Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study
X.M. Hart, Friederike Amann, Jonas Brand, et al.
Pharmacopsychiatry (2023) Vol. 56, Iss. 02, pp. 73-80
Open Access | Times Cited: 4
Therapeutic reference range for duloxetine in the treatment of depression revised: A systematic review and meta-analysis
Friederike Amann, M. Kochtyrew, Gerald Zernig, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104077-104077
Open Access | Times Cited: 1
Systematic review of studies using platelet serotonin content to assess bioeffect of serotonin reuptake inhibitors at the serotonin transporter
George M. Anderson, Isabella Bruno-Pacella
Psychopharmacology (2022) Vol. 240, Iss. 1, pp. 1-13
Closed Access | Times Cited: 6
The reference range of lamotrigine in the treatment of epilepsy in children: a systematic review
Jingjing Chen, Liang Huang, Linan Zeng, et al.
European Journal of Clinical Pharmacology (2023) Vol. 80, Iss. 1, pp. 1-10
Open Access | Times Cited: 2
Association between olanzapine plasma concentrations and treatment response: A systematic review, meta-analysis and individual participant data meta-analysis
Jed Hadjoudj, Céline Konecki, Catherine Féliu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116236-116236
Open Access
Serum Concentration–Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine
Regina Taurines, Gesa Kunkel, Stefanie Fekete, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 772-772
Open Access
UPLC-MS/MS determination of 71 neuropsychotropic drugs in human serum
Weifeng Jin, Jianhua Wang, Shuzi Chen, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32274-e32274
Open Access
Therapeutic drug monitoring in children and adolescents with schizophrenia-spectrum, affective, behavioural, tic and other psychiatric disorders treated with aripiprazole: results of the TDM-VIGIL pharmacovigilance study
Jessica Riegger, Karin Egberts, Hans‐Willi Clement, et al.
Journal of Neural Transmission (2024) Vol. 132, Iss. 2, pp. 295-312
Open Access
Measuring serum concentrations of psychotropics- Valuable tool for decision making or waste of money?
Heinz Grunze
European Neuropsychopharmacology (2023) Vol. 76, pp. 20-22
Closed Access | Times Cited: 1
Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes
Juan José Fernández Miranda, Silvia Díaz-Fernández, F.J. Cepeda Piorno, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 165-165
Open Access
Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
X.M. Hart, Christoph Hiemke, H.‐W. Clement, et al.
Pharmacopsychiatry (2022) Vol. 55
Closed Access | Times Cited: 1
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Katja Wesner, Christoph Hiemke, N. Bergemann, et al.
Pharmacopsychiatry (2022) Vol. 55
Closed Access | Times Cited: 1
Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia. Treatment Adherence, Effectiveness, Tolerability, and Safety
Juan José Fernández Miranda, Silvia Díaz-Fernández
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 2093-2103
Open Access
Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
Xenija Lense, Gerhard Gründer, Ursula Havemann‐Reinecke, et al.
Pharmacopsychiatry (2022) Vol. 55
Closed Access
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range
Luzie Eichentopf, Christoph Hiemke, Andreas Conca, et al.
Pharmacopsychiatry (2022) Vol. 55
Closed Access
Page 1

Scroll to top